Department of Health and Human Services August 18, 2017 – Federal Register Recent Federal Regulation Documents
Results 1 - 11 of 11
Bayer Healthcare Pharmaceuticals; Withdrawal of Approval of a New Drug Application for BAYCOL (cerivastatin sodium) Tablets, 0.05 Milligrams, 0.1 Milligrams, 0.2 Milligrams, 0.3 Milligrams, 0.4 Milligrams, and 0.8 Milligrams
The Food and Drug Administration (FDA) is withdrawing approval
Agency Information Collection Activities: Proposed Collection; Comment Request
This notice announces the intention of the Agency for
Agency Information Collection Activities: Submission for OMB Review; Comment Request
The Centers for Medicare & Medicaid Services (CMS) is
Effective Methods for Implementing Water Management Programs (WMPs) To Reduce Growth of Transmission of Legionella spp.
The Centers for Disease Control and Prevention (CDC) in the
Government-Owned Inventions; Availability for Licensing
The invention listed below is owned by an agency of the U.S.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.